Statement of Academic Contributions, Goals and Plans



Publications by Year

Faculty Name, Ph.D.

Assistant Professor of Department

University of Southern California Keck School of Medicine

|Year |Publications |First author |Second author |Senior author |Other |

|1998 |1 |1 | | | |

|2000 |3 |2 |1 | | |

|2001 |3 |2 |1 | | |

|2002 |2 |1 |1 | | |

|2003 |1 |1 | | | |

|2004 |1 | | |1 | |

|2006 |1 | | |1 | |

|2007 |3 | | |2 |1 |

|2008 |3 | | |2 |1 |

|2009 |4 | | |1 |3* |

| | | | | | |

|Total |22 |7 |3 |7 |5 |

* Two of these are in press

Publications: Impact Factors and Citation Counts

Faculty Name, Ph.D.

Assistant Professor of Department

University of Southern California Keck School of Medicine

|Publication |Journal |Impact Factor |Citation Counts |

|1. Rice et al., 1998 |Oncogene |6.44 |113 |

|2. Domann et al., 2000 |Int J Cancer |4.56 |109 |

|3. Rice et al., 2000 |Nucleic Acids Res |6.95 |43 |

|4. Rice et al., 2000 |Carcinogenesis |5.41 |59 |

|5. Nakayama et al. 2001 |Science |26.37 |634 |

| Rice et al., 2001 |Curr Opin Cell Biol (review) |13.44 |238 |

| Rice et al., 2001 |Nature (review) |28.75 |62 |

|6. Nishioka et al., 2002 |Mol Cell |13.16 |150 |

|7. Rice et al., 2002 |Genes & Dev |14.80 |83 |

|8. Rice et al., 2003 |Mol Cell |13.16 |240 |

| Grewal et al., 2004 |Curr Opin Cell Biol (review) |13.44 |90 |

|9. Sims et al., 2006 |J Biol Chem |5.58 |32 |

|10. Wu et al., 2007 |FEBS Letts |3.26 |7 |

|11. Jensky et al., 2007 |Euro J Applied Physiol |1.75 |2 |

| Spektor et al., 2007 |Nature Cell Biol (review) |17.62 |0 |

|12. Sims et al., 2008 |Mol Cell Biol |6.42 |1 |

|13. Houston et al., 2008 |J Biol Chem |5.58 |10 |

|14. Kalakonda et al., 2008 |Oncogene |6.44 |8 |

|15. Dieli et al., 2009 |J Appl Physiol |3.66 |0 |

|16. Spektor et al., 2009 |Proc Nat Acad Sci USA |9.38 |0 |

| Dieli et al., 2009 |Acta Physiologica |2.46 |In press |

| Dieli et al., 2009 |J Appl Physiol |3.66 |In press |

| | | | |

| |Average: |9.65 |86/pub |

Research Grants Awarded

Faculty Name, Ph.D.

Assistant Professor of Department

University of Southern California Keck School of Medicine

1. Cancer Research Scholar Award 07/01/04 – 06/30/06

Total Direct Costs: $200,000 Total F&A: $16,000**

Genome-wide analysis of histone methylation as an indicator of cancer progression

The goal of this project was to utilize high throughput ChIP-chip technology to identify specific changes in histone H3 Lys9 modifications during the progression of breast cancer to a malignant state.

Principal Investigator, 5% effort

(**Also provided a GM vehicle to USC for $31,000 MSRP)

2. The Foundation Award 08/01/04 – 07/31/05

Total Direct Costs: $50,000 Total F&A: $0

Genome-wide analysis of heterochromatic alterations during sporadic breast cancer progression

The goal of this project was to identify specific heterochromatic changes, by investigating various histone modifications, that were altered during sporadic breast cancer progression.

Principal Investigator, 0% effort

3. Department of Defense (IDEA PC040160) 10/01/04 – 09/30/07

Total Direct Costs: $610,313 Total F&A: $381,446

Androgen receptor-mediated escape from androgen ablation therapy

The major goal of this project is to determine the mechanisms by which hormone refractory prostate cancer is still affected by signaling via the androgen receptor.

Co-Investigator (PI: Gerhard Coetzee, Ph.D.), 5% effort

4. American Cancer Society (IRG-58-007-45) 01/01/05 – 12/31/05

Total Direct Costs: $20,000 Total F&A: $0

Histone H4 methylation in cancer

The main goal of this pilot project was to determine the endogenous target genes affected by the histone H4 methylation silencing pathway.

Principal Investigator, 0% effort

5. The Foundation 07/01/05 – 06/30/06

Total Direct Costs: $100,000 Total F&A: $0

Using innovative technologies to improve the detection and treatment of sporadic breast cancer

The goal of this project was to identify putative histone markers that are indicative of sporadic breast cancer.

Principal Investigator, 0% effort

6. California Breast Cancer Research Program (IDEA 11IB-0085) 08/01/05 – 07/31/06

Total Direct Costs: $100,000 Total F&A: $62,500

Histone methylation as a marker of breast cancer progression

The goal of this project was to identify genomic changes in H4 Lys20 methylation during breast cancer progression to be used as diagnostic markers.

Principal Investigator, 5% effort

7. Pew Scholar Award 07/01/06 – 06/30/10

Total Direct Costs: $220,800 Total F&A: $19,200

Signaling to the epigenome: reading the histone code

The goals of this project are to define the genomic regions of H4K20 methylation by ChIP-chip and identify novel histone modification-specific binding proteins in vivo using mammalian tethered catalysis (MTeC).

Principal Investigator, 8.25% effort

8. Faculty Research Award 07/01/06 – 06/30/07

Total Direct Costs: $25,000 Total F&A: $0

Identification of histone H3 lysine 9 methyl-binding proteins

The goal of this proposal is to further develop our novel mammalian tethered catalysis (MTeC) method to identify histone H3 lysine 9 methyl-specific binding proteins in vivo.

Principal Investigator, 0% effort

9. NIH: National Cancer Institute (1 R01 GM075094) 08/01/07 – 07/31/12

Total Direct Costs: $950,000 Total F&A: $598,500

Molecular mechanisms of gene silencing by H4 methylation

The major goals of this proposal are to elucidate the key components and genes controlled by the histone H4 lysine 20 methylation gene silencing pathway.

Principal Investigator, 42% effort

Grants Pending

1. NIH: National Cancer Institute (1 R01 ES018860) 04/01/10 – 03/31/13

Total Direct Costs: $1,000,000 Total F&A: $630,000

Role of PR-Set7 and histone H4K20me1 in DNA repair and genomic stability

The goals of this project are to determine the molecular roles of PR-Set7 and its monomethylation of histone H4 lysine 20 (H4K20me1) in suppressing DNA damage and genomic instability.

Principal Investigator, 33% effort

2. Medical Research Trust 01/01/10 – 12/31/11

Total Direct Costs: $125,000 Total F&A: $25,000

Elucidating the role of PR-Set7 in protection against DNA damage, genomic instability and oncogenesis

The goals of this project are to determine the molecular roles of PR-Set7 in protecting the human genome against DNA damage and genomic instability.

Principal Investigator, 0% effort

Grants Awarded to Personnel

1. USC/Norris Breast Cancer Research Training Program Fellowship

Awarded to 10/01/05 – 9/30/06

2. NIH GMCB Training Program Fellowship

Awarded to 07/01/06 – 06/30/08

3. Predoctoral Scholarship Award

Awarded to 07/01/08 – 6/30/09

4. NIH National Research Service Award

Awarded to 09/01/08 – 08/31/11

5. California Institute for Regenerative Medicine (CIRM) Scholar Fellowship

Awarded to 07/01/08 – 06/30/10

................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download